XML 101 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value of Financial Instruments
9 Months Ended
Sep. 30, 2012
Fair Value of Financial Instruments [Abstract]  
Fair Value of Financial Instruments Disclosure

 

 

12.  FAIR VALUE OF FINANCIAL INSTRUMENTS 

 

The fair value of financial instruments has been estimated by the Company using available market information as of September 30, 2012 and December 31, 2011, and valuation methodologies considered appropriate. The estimates presented are not necessarily indicative of amounts the Company could realize in a current market exchange (in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

September 30, 2012

 

December 31, 2011

 

Carrying

 

Estimated Fair

 

Carrying

 

Estimated Fair

 

Amount

 

Value

 

Amount

 

Value

Assets:

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

$

240,650 

 

$

240,650 

 

$

129,865 

 

$

129,865 

Available-for-sale securities

 

35,419 

 

 

35,419 

 

 

31,582 

 

 

31,582 

Trading securities

 

36,235 

 

 

36,235 

 

 

30,486 

 

 

30,486 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

Credit Facility

 

4,356,562 

 

 

4,360,411 

 

 

5,979,383 

 

 

5,780,877 

8⅞% Senior Notes

 

 -

 

 

 -

 

 

1,777,617 

 

 

1,842,322 

8% Senior Notes

 

2,023,414 

 

 

2,202,500 

 

 

1,000,000 

 

 

995,000 

7% Senior Notes

 

1,200,000 

 

 

1,278,000 

 

 

 -

 

 

 -

5% Senior Secured Notes

 

1,600,000 

 

 

1,658,000 

 

 

 -

 

 

 -

Receivables Facility and other debt

 

343,052 

 

 

343,052 

 

 

41,143 

 

 

41,143 

 

The estimated fair value is determined using the methodologies discussed below in accordance with accounting standards related to the determination of fair value based on the U.S. GAAP fair value hierarchy as discussed in Note 13.  The estimated fair value for financial instruments with a fair value that does not equal its carrying value is considered a Level 2 valuation.  The Company utilizes the market approach and obtains indicative pricing from the administrative agent to the Credit Facility to determine fair values, which are validated through subscription services such as Bloomberg where relevant. 

 

Cash and cash equivalents.  The carrying amount approximates fair value due to the short-term maturity of these instruments (less than three months). 

 

Available-for-sale securities.  Estimated fair value is based on closing price as quoted in public markets. 

 

Trading securities.  Estimated fair value is based on closing price as quoted in public markets. 

 

Credit Facility.  Estimated fair value is based on information from the Company’s bankers regarding relevant pricing for trading activity among the Company’s lending institutions. 

 

8⅞% Senior Notes.  Estimated fair value is based on the average bid and ask price as quoted by the bank who served as underwriters in the sale of these notes. 

 

8% Senior Notes.  Estimated fair value is based on the average bid and ask price as quoted by the bank who served as underwriters in the sale of these notes. 

 

7⅛% Senior Notes.  Estimated fair value is based on the average bid and ask price as quoted by the bank who served as underwriters in the sale of these notes. 

 

5⅛% Senior Secured Notes.  Estimated fair value is based on the average bid and ask price as quoted by the bank who served as underwriters in the sale of these notes. 

 

Other debt.  The carrying amount of all other debt approximates fair value due to the nature of these obligations. 

 

 

 

Interest rate swaps.  The fair value of interest rate swap agreements is the amount at which they could be settled, based on estimates calculated by the Company using a discounted cash flow analysis based on observable market inputs and validated by comparison to estimates obtained from the counterparty. The Company incorporates credit valuation adjustments (“CVAs”) to appropriately reflect both its own nonperformance or credit risk and the respective counterparty’s nonperformance or credit risk in the fair value measurements. In adjusting the fair value of its interest rate swap agreements for the effect of nonperformance or credit risk, the Company has considered the impact of any netting features included in the agreements. 

 

The Company assesses the effectiveness of its hedge instruments on a quarterly basis. For the three and nine months ended September 30, 2012 and 2011, the Company completed an assessment of the cash flow hedge instruments and determined the hedges to be highly effective. The Company has also determined that the ineffective portion of the hedges do not have a material effect on the Company’s consolidated financial position, operations or cash flows. The counterparties to the interest rate swap agreements expose the Company to credit risk in the event of nonperformance. However, at September 30, 2012, each swap agreement entered into by the Company was in a net liability position so that the Company would be required to make the net settlement payments to the counterparties; the Company does not anticipate nonperformance by those counterparties. The Company does not hold or issue derivative financial instruments for trading purposes. 

 

Interest rate swaps consisted of the following at September 30, 2012:  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Swap #

 

Notional Amount (in 000’s)

 

Fixed Interest Rate

 

Termination Date

 

Fair Value of Liability (in 000’s)

1

 

$

100,000 

 

3.352 

%

 

October 23, 2012

 

$

186 

2

 

 

125,000 

 

4.375 

%

 

November 23, 2012

 

 

729 

3

 

 

75,000 

 

4.380 

%

 

November 23, 2012

 

 

436 

4

 

 

150,000 

 

5.020 

%

 

November 30, 2012

 

 

1,146 

5

 

 

200,000 

 

2.242 

%

 

February 28, 2013

 

 

1,558 

6

 

 

100,000 

 

5.023 

%

 

May 30, 2013

 

 

3,114 

7

 

 

300,000 

 

5.242 

%

 

August 6, 2013

 

 

12,533 

8

 

 

100,000 

 

5.038 

%

 

August 30, 2013

 

 

4,313 

9

 

 

50,000 

 

3.586 

%

 

October 23, 2013

 

 

1,729 

10

 

 

50,000 

 

3.524 

%

 

October 23, 2013

 

 

1,696 

11

 

 

100,000 

 

5.050 

%

 

November 30, 2013

 

 

5,495 

12

 

 

200,000 

 

2.070 

%

 

December 19, 2013

 

 

4,217 

13

 

 

100,000 

 

5.231 

%

 

July 25, 2014

 

 

8,824 

14

 

 

100,000 

 

5.231 

%

 

July 25, 2014

 

 

8,823 

15

 

 

200,000 

 

5.160 

%

 

July 25, 2014

 

 

17,390 

16

 

 

75,000 

 

5.041 

%

 

July 25, 2014

 

 

6,359 

17

 

 

125,000 

 

5.022 

%

 

July 25, 2014

 

 

10,555 

18

 

 

100,000 

 

2.621 

%

 

July 25, 2014

 

 

4,095 

19

 

 

100,000 

 

3.110 

%

 

July 25, 2014

 

 

4,981 

20

 

 

100,000 

 

3.258 

%

 

July 25, 2014

 

 

5,249 

21

 

 

200,000 

 

2.693 

%

 

October 26, 2014

 

 

9,575 

22

 

 

300,000 

 

3.447 

%

 

August 8, 2016

 

 

32,294 

23

 

 

200,000 

 

3.429 

%

 

August 19, 2016

 

 

21,510 

24

 

 

100,000 

 

3.401 

%

 

August 19, 2016

 

 

10,654 

25

 

 

200,000 

 

3.500 

%

 

August 30, 2016

 

 

22,165 

26

 

 

100,000 

 

3.005 

%

 

November 30, 2016

 

 

9,584 

 

 

 

The Company is exposed to certain risks relating to its ongoing business operations. The risk managed by using derivative instruments is interest rate risk. Interest rate swaps are entered into to manage interest rate fluctuation risk associated with the term loans in the Credit Facility. Companies are required to recognize all derivative instruments as either assets or liabilities at fair value in the condensed consolidated statement of financial position. The Company designates its interest rate swaps as cash flow hedges. For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative is reported as a component of other comprehensive income (“OCI”) and reclassified into earnings in the same period or periods during which the hedged transactions affect earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings. 

 

Assuming no change in September 30, 2012 interest rates, approximately $102.0 million of interest expense resulting from the spread between the fixed and floating rates defined in each interest rate swap agreement will be recognized during the next 12 months. If interest rate swaps do not remain highly effective as a cash flow hedge, the derivatives’ gains or losses resulting from the change in fair value reported through OCI will be reclassified into earnings. 

 

The following tabular disclosure provides the amount of pre-tax loss recognized as a component of OCI during the three and nine months ended September 30, 2012 and 2011 (in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amount of Pre-Tax Loss Recognized in OCI (Effective Portion)

Derivatives in Cash Flow Hedging Relationships

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

2012

 

2011

 

2012

 

2011

Interest rate swaps

 

$

(20,689)

 

$

(49,499)

 

$

(65,515)

 

$

(113,071)

 

 

The following tabular disclosure provides the location of the effective portion of the pre-tax loss reclassified from accumulated other comprehensive loss (“AOCL”) into interest expense on the condensed consolidated statements of income during the three and nine months ended September 30, 2012 and 2011 (in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amount of Pre-Tax Loss Reclassified from AOCL into Income (Effective Portion)

Location of Loss Reclassified from AOCL into Income (Effective Portion)

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

2012

 

2011

 

2012

 

2011

Interest expense, net

 

$

33,606 

 

$

53,758 

 

$

110,532 

 

$

160,331 

 

 

The fair values of derivative instruments in the condensed consolidated balance sheets as of September 30, 2012 and December 31, 2011 were as follows (in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asset Derivatives

 

 

Liability Derivatives

 

 

September 30, 2012

 

December 31, 2011

 

 

September 30, 2012

 

December 31, 2011

 

 

Balance Sheet Location

 

 

Fair Value

 

Balance Sheet Location

 

 

Fair Value

 

 

Balance Sheet Location

 

 

Fair Value

 

Balance Sheet Location

 

 

Fair Value

Derivatives designated as hedging instruments

 

Other assets, net

 

$

 -

 

Other assets, net

 

$

 -

 

 

Other long-term liabilities

 

$

209,210 

 

Other long-term liabilities

 

$

254,228